Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Simon Warner

Dr. Simon Warner

Head of Licensing & Ventures - Life Sciences

Dr Simon Warner has over twenty-five years of experience in commercial biotechnology in various roles, raising venture capital, securing strategic partners and philanthropic funding sources. He joined Oxford University Innovation in 2021 as Head of Licensing and Ventures, Life Sciences.

Previous career highlights have included the successful sale of Oxitec, a spin-out from the University of Oxford, where he was CSO. Oxitec was purchased by synthetic biology specialist, Intrexon in 2015 for $160M, and following the sale Simon led further initiatives securing funding from the Bill and Melinda Gates Foundation for the control of mosquitoes that transmit malaria and with Bayer to control devastating crop insect pests.

Simon worked for Syngenta and had a role in technology, strategy and innovation, monetising IP assets in return for cash or equity in start-ups for Syngenta and in-licensing IP rights to support future commercial products. Simon has a biochemistry degree from University College London and a PhD in plant molecular biology from the University of Leicester.